In that study, NEK5 was shown to be overexpressed in breast cancer tissues, suggesting that it can promote the growth of breast cancer cells, whereas the mechanism underlying its effects can be explained by its interaction with, and up-regulation of, cyclin A2. The gene discussed is CCNA2; the disease is breast carcinoma.